Summary & Overview
HCPCS C9250: Human Plasma Fibrin Sealant (Artiss), 2 ml
HCPCS Level II code C9250 denotes a 2 ml vial of human plasma fibrin sealant (Artiss), vapor-heated and solvent-detergent processed, used as a surgical hemostatic and tissue sealant. This biologic adjunct is applied during operative and procedural care to control bleeding and facilitate tissue adherence, making it relevant across surgical specialties including plastic, reconstructive, and general surgery.
Key national payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how C9250 is classified for billing, summarizes payer coverage patterns, and highlights the clinical contexts in which the product is typically used.
Readers will find benchmarks for utilization and reimbursement structures, summaries of relevant payer policy themes, and clinical context for appropriate service lines and sites of service. The report also identifies common modifiers associated with procedural supply billing and notes gaps where data were not provided. This summary is intended for a national audience of billing professionals, revenue cycle managers, and surgical clinical leadership seeking concise guidance on the classification and billing context of HCPCS Level II code C9250.
Billing Code Overview
HCPCS Level II code C9250 represents human plasma fibrin sealant, vapor-heated, solvent-detergent (Artiss), 2 ml. This product is a biologic surgical hemostatic and tissue sealant derived from human plasma and prepared using vapor-heating and solvent-detergent processes.
Service Type: Surgical hemostatic/tissue adhesive application
Typical Site of Service: Operating room or procedural suite
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult undergoing a surgical procedure—commonly dermatologic, plastic/reconstructive, head and neck, or orthopedic soft-tissue surgery—where meticulous hemostasis and tissue approximation are required. The product described, C9250 (human plasma fibrin sealant, vapor-heated, solvent-detergent, 2 ml; trade name Artiss), is used intraoperatively as a biologic adhesive and hemostatic adjunct to reduce bleeding, secure skin grafts or flaps, and promote tissue adherence.
A realistic scenario: A 62-year-old patient presents for Mohs micrographic surgery with a large full-thickness cheek defect that will be reconstructed with a local advancement flap and a split-thickness skin graft. After achieving primary hemostasis with electrocautery and sutures, the surgical team applies C9250 fibrin sealant to the graft bed to enhance graft take and limit postoperative hematoma. Use is performed in the operating room under monitored anesthesia care; nursing documents lot number, expiration, and amount used; the surgeon documents indication, application site, and clinical effect. The product is billed with C9250 and may be appended with appropriate modifiers reflecting service circumstances (for example, modifier 62 for co-surgery or modifier AS for physician assistant when applicable). Typical sites of service include the hospital operating room, ambulatory surgery center, and occasionally office-based procedure rooms for selected dermatologic surgeries.
Clinical workflow steps:
-
Preoperative: consent includes use of biologic adhesives and discussion of plasma-derived product.
-
Intraoperative: standard hemostasis achieved;
C9250prepared per manufacturer instructions; applied to graft or flap interface; allowed to set for recommended time before dressing and closure.